Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy

Lung adenocarcinoma (LUAD) is a devastating disease with poor patient survival. Cancer immunotherapy has revolutionized the treatment of LUAD, but only a limited number of patients effectively respond to this treatment. Thus, the work to elucidate the LUAD immune heterogeneity could be crucial in de...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Cell Dev Biol
Главные авторы: Song, Yang, Yan, Shi, Fan, Weina, Zhang, Mengyan, Liu, Wei, Lu, Hailing, Cao, Mengru, Hao, Chenguang, Chen, Lin, Tian, Fanglin, Zhan, Yuning, Cai, Li, Xing, Ying
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Cell and Developmental Biology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348081/
https://ncbi.nlm.nih.gov/pubmed/32719796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.00550
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы